$NIMU
NON INVASIVE MONITORING SYSTEMS INC /FL/

2014 Form 10-K Financial Statement

#000114420414063035 Filed on October 27, 2014

View on sec.gov

Income Statement

Concept 2014 2013 Q3 2013
Revenue $13.00K $50.00K $109.0K
YoY Change -88.07% 0.0% -56.4%
Cost Of Revenue $6.000K $30.00K $41.00K
YoY Change -85.37% 64.0%
Gross Profit $7.000K $20.00K $68.00K
YoY Change -89.71% -60.0% -69.78%
Gross Profit Margin 53.85% 40.0% 62.39%
Selling, General & Admin $319.0K $110.0K $444.0K
YoY Change -28.15% -31.25% -25.88%
% of Gross Profit 4557.14% 550.0% 652.94%
Research & Development $1.000K $0.00 $3.000K
YoY Change -66.67% -92.11%
% of Gross Profit 14.29% 0.0% 4.41%
Depreciation & Amortization $0.00 $10.00K $5.000K
YoY Change -100.0% -70.59%
% of Gross Profit 0.0% 50.0% 7.35%
Operating Expenses $320.0K $110.0K $447.0K
YoY Change -28.41% -31.25% -29.83%
Operating Profit -$313.0K -$90.00K -$379.0K
YoY Change -17.41% -18.18% -8.01%
Interest Expense -$130.0K -$30.00K -$130.0K
YoY Change 0.0% 0.0% 8.33%
% of Operating Profit
Other Income/Expense, Net $2.000K $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$440.0K -$120.0K -$510.0K
YoY Change -13.73% -20.0% -7.27%
Income Tax -$443.0K $0.00 -$507.0K
% Of Pretax Income
Net Earnings -$443.0K -$120.0K -$507.0K
YoY Change -12.62% -20.0% -8.48%
Net Earnings / Revenue -3407.69% -240.0% -465.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$5.574K -$1.507K -$7.078K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2014 2013 Q3 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K $300.0K $300.0K
YoY Change -93.33% 400.0% 400.0%
Cash & Equivalents $296.0K
Short-Term Investments
Other Short-Term Assets $50.00K $50.00K $50.00K
YoY Change 0.0% 66.67% 66.67%
Inventory $460.0K $462.0K $460.0K
Prepaid Expenses
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $530.0K $805.0K $810.0K
YoY Change -34.57% 33.06% 32.79%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $5.000K $10.00K
YoY Change -100.0% -54.55% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $5.000K $0.00
YoY Change -54.55% -100.0%
TOTAL ASSETS
Total Short-Term Assets $530.0K $805.0K $810.0K
Total Long-Term Assets $0.00 $5.000K $0.00
Total Assets $530.0K $810.0K $810.0K
YoY Change -34.57% 31.49% 30.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $910.0K $750.0K $750.0K
YoY Change 21.33% 20.97% 20.97%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.200M $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $2.110M $758.0K $760.0K
YoY Change 177.63% -53.21% -53.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.200M $1.200M
YoY Change -100.0% 4.35% 700.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $1.200M $1.200M
YoY Change -100.0% 700.0% 700.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.110M $758.0K $760.0K
Total Long-Term Liabilities $0.00 $1.200M $1.200M
Total Liabilities $2.110M $1.958M $1.960M
YoY Change 7.65% 10.62% 10.73%
SHAREHOLDERS EQUITY
Retained Earnings -$23.88M
YoY Change 2.17%
Common Stock $789.0K
YoY Change 14.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.590M -$1.148M -$1.150M
YoY Change
Total Liabilities & Shareholders Equity $530.0K $810.0K $810.0K
YoY Change -34.57% 31.49% 30.65%

Cashflow Statement

Concept 2014 2013 Q3 2013
OPERATING ACTIVITIES
Net Income -$443.0K -$120.0K -$507.0K
YoY Change -12.62% -20.0% -8.48%
Depreciation, Depletion And Amortization $0.00 $10.00K $5.000K
YoY Change -100.0% -70.59%
Cash From Operating Activities -$280.0K -$130.0K -$311.0K
YoY Change -9.97% 116.67% 182.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $4.000K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $501.0K
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 $551.0K
YoY Change -100.0% -100.0% 451.0%
NET CHANGE
Cash From Operating Activities -280.0K -130.0K -$311.0K
Cash From Investing Activities $4.000K $0.00
Cash From Financing Activities $0.00 0.000 $551.0K
Net Change In Cash $4.000K -130.0K $240.0K
YoY Change -98.33% 1200.0% -2500.0%
FREE CASH FLOW
Cash From Operating Activities -$280.0K -$130.0K -$311.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78942423 shares
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1200000 USD
CY2014Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2013Q3 us-gaap Liabilities
Liabilities
1958000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
2113000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
789000 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
789000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21927000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21931000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23880000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24323000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-1148000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
-1587000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
810000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
526000 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><i>Use of Estimates.</i></b> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions, such as accounts receivable, stock based compensation, warranty accrual and deferred taxes as estimates, that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Such items include input variables for stock based compensation, accounts receivable, warranty accrual and deferred taxes. Actual results could differ materially from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
9000 USD
CY2014Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
9000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
453000 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
446000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1281250 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
235000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
613750 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
378750 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
378750 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
378750 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.573
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.000
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.000
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.000
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.000
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.791
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.264
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.335
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.380
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.380
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.380
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M17D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y1M17D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y1M17D
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16139950 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15904950 shares
CY2013Q3 us-gaap Line Of Credit
LineOfCredit
1000000 USD
CY2014Q3 us-gaap Line Of Credit
LineOfCredit
1000000 USD
CY2007Q3 nimu Payments On Approval Of Product Prototype Concepts And Designs
PaymentsOnApprovalOfProductPrototypeConceptsAndDesigns
150000 USD
CY2014Q3 us-gaap Purchase Obligation
PurchaseObligation
13900000 USD
CY2013Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
110000 USD
CY2014Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
110000 USD
CY2013 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
39000 USD
CY2014 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
36000 USD
CY2013Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000 USD
CY2007Q3 us-gaap Manufacturing Costs
ManufacturingCosts
471000 USD
CY2007Q3 us-gaap Cost Of Utilities
CostOfUtilities
150000 USD
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78942423 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78942423 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78942423 shares
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Companys common stock as of the grant date or an exercise price of not less than 110% of the fair value for a 10% shareholder.
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1200000 USD
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
1200000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
115000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
111000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110000 USD
CY2013 us-gaap Depreciation
Depreciation
5000 USD
CY2014 us-gaap Depreciation
Depreciation
0 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
93000 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12000 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
41000 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
444000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
319000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1000 USD
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
488000 USD
CY2014 us-gaap Costs And Expenses
CostsAndExpenses
326000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-379000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-313000 USD
CY2013 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-128000 USD
CY2014 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-132000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-507000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-443000 USD
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72052 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78942 shares
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
-1154000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
240000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-275000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-311000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-279000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
501000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
551000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
12000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
4000 USD
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-17000 USD
CY2014 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-38000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7000 USD
CY2013 nimu Increase Decrease In Prepaid Expenses Deposits And Other Current Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherCurrentAssets
14000 USD
CY2014 nimu Increase Decrease In Prepaid Expenses Deposits And Other Current Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherCurrentAssets
3000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
138000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
155000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
296000 USD
CY2013 nimu Transfer Of Tooling And Equipment To Inventory
TransferOfToolingAndEquipmentToInventory
1000 USD
CY2014 nimu Transfer Of Tooling And Equipment To Inventory
TransferOfToolingAndEquipmentToInventory
0 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2013 us-gaap Other Income
OtherIncome
-128000 USD
CY2014 us-gaap Other Income
OtherIncome
-130000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
501000 USD
CY2013 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
0 USD
CY2014 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
0 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2014 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2013Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2014Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1150000 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
125000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
77000 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-07-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
NON INVASIVE MONITORING SYSTEMS INC /FL/
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000720762
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 dei Entity Public Float
EntityPublicFloat
12300000 USD
CY2014 dei Trading Symbol
TradingSymbol
NIMU
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78942423 shares
CY2014Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
0 USD
CY2013Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
0 USD
CY2014Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
50000 USD
CY2014Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
41000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
40000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
7000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
47000 USD
CY2013Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
50000 USD
CY2013Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5692000 USD
CY2014Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5859000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-513000 USD
CY2014 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-443000 USD
CY2013 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
6000 USD
CY2014 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-507000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-443000 USD
CY2013Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5692000 USD
CY2014Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5859000 USD
CY2013 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
27000 USD
CY2014 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
166000 USD
CY2014 nimu Tax Position Realization Percent
TaxPositionRealizationPercent
0.5 pure
CY2013 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4000 USD

Files In Submission

Name View Source Status
0001144204-14-063035-index-headers.html Edgar Link pending
0001144204-14-063035-index.html Edgar Link pending
0001144204-14-063035.txt Edgar Link pending
0001144204-14-063035-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
nimu-20140731.xml Edgar Link completed
nimu-20140731.xsd Edgar Link pending
nimu-20140731_cal.xml Edgar Link unprocessable
nimu-20140731_def.xml Edgar Link unprocessable
nimu-20140731_lab.xml Edgar Link unprocessable
nimu-20140731_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v391510_10k.htm Edgar Link pending
v391510_ex21-1.htm Edgar Link pending
v391510_ex31-1.htm Edgar Link pending
v391510_ex31-2.htm Edgar Link pending
v391510_ex32-1.htm Edgar Link pending
v391510_ex32-2.htm Edgar Link pending